An article in the Record published by Washington University In St. Louis today about a new approach to the treatment of Endometrial Cancer (Cancer that invades the uterine wall) is wonderful news for many women. Endometrial Cancer is the most common Gynecological cancers in the US. The article states that 40,000 women will be diagnosed with this type of cancer this year and 7,500 of those women will die of the disease according to the American Cancer Society.
The article states that 'by introducing a commercially available inhibitor drug, PD173074, the researchers showed that they could stop cell growth and induce dell death in endometrial cell lines that contained the altered FGFR2 gene'. This gene causes endometrial cells to grow out of control. This is a wonderful breakthrough in yet another cancer treatment that is claiming the lives of too many women.
If you would like to read more on this new treatment go to Record to read the full article.
0 comments:
Post a Comment